KA Imaging achieves Health Canada license and FDA clearance for innovative X-ray technology

Wednesday, September 30, 2020

Digital X-ray technology developed by a University of Waterloo spinoff company has won approval from Health Canada.

A medical device licence issued for Reveal 35C, a dual-energy X-ray detector created by KA Imaging, follows clearance from the Food and Drug Administration in the United States earlier this month.

“Getting this Health Canada licence is a major step forward for KA Imaging, especially coupled with the recent FDA clearance,” Amol Karnick (BASc '95), an engineering alumnus who is president and CEO of the company, said in a media release.

Sample images made with X-ray technology developed by Waterloo Engineering startup KA Imaging.

Sample images made with X-ray technology developed by Waterloo startup KA Imaging.

KA Imaging was founded in 2015 by Karnick and fellow alumni Sina Ghanbarzadeh (MASc '14) and Karim S. Karim (BASc '99, PhD '03), a professor of electrical and computer engineering and executive director of the Centre for Bioengineering and Biotechnology at Waterloo.

The company’s flagship product is an inexpensive, portable X-ray detector that can differentiate between bone and soft tissue in a single exposure.

It is now being tested on lung cancer patients at Grand River Hospital in Kitchener and for detection of pneumonia, including cases caused by COVID-19, at a Toronto-based hospital.

Full article: [Waterloo Stories]

  1. 2022 (6)
    1. September (2)
    2. July (1)
    3. June (3)
  2. 2021 (4)
    1. November (1)
    2. August (2)
    3. June (1)
  3. 2020 (9)
    1. November (1)
    2. October (2)
    3. September (2)
    4. June (1)
    5. April (1)
    6. March (2)
  4. 2019 (11)
  5. 2018 (51)
  6. 2017 (45)
  7. 2016 (25)
  8. 2015 (26)
  9. 2014 (6)
  10. 2013 (13)
  11. 2012 (6)